Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2513-2517

  Demirhan, Ilhan ^a   Chandra, Angelika ^a   Sarin, Prem S ^b   Hasselmayer, Oliver ^a   Hofmann, Dieter ^a   Chandra, Prakash ^a,c  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Antiviral activity; HIV 1; Sulfhydryl compounds; Transactivation

Indexed keywords

DIMERCAPROL; THIOL DERIVATIVE; TRANSACTIVATOR PROTEIN; UNITHIOL;

ANTIVIRAL ACTIVITY; ARTICLE; CHELATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CHELATING AGENTS; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; SULFHYDRYL COMPOUNDS; TRANS-ACTIVATION (GENETICS); U937 CELLS; VIRUS REPLICATION;

EID: 0033853568     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chandra P, Vogel A and Gerber T: Inhibitors of retroviral DNA polymerase: Their implication in the treatment of AIDS. Cancer Res 45: 4677-4684, 1985.
2. Chandra P, Chandra A, Demirhan I and Gerber T: Molecular Mechanisms for the control of human immunodeficiency virus infection. Pharm. and Ther., Suppl. (Edts. E. Borowski and D. Shugar), pp. 25-46, 1990. (Pharmacol and Ther. 1990)
3. De Clercq E: HIV Inhibitors Targeted at the Reverse Transcriptase. AIDS Res Hum Retroviruses 8: 119-134, 1992.
4. Chandra P, Chandra A, Gerber T and Demirhan I: Molecular Approaches to control replication of AIDS-associated retroviruses: Regulatory genes as potential targets. Progress in AIDS Research (Edt. M. Schauzu), Medizin Verlag, München 213-226, 1990.
5. Demirhan I, Hasselmayer O, Hofmann D, Chandra A, Svinarchuk FP, Vlassov VV, Engels J and Chandra P: Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides. Virus Genes 9: 113-119, 1994.
6. Haseltine WA and Wong-Staal F (Edts.): Genetic Structure and Regulation of HIV. Raven Press, New York, 1-42, 1991.
7. Reddy TR, Suhasini M, Rappaport J, Looney DJ, Kraus G and Wong-Staal F: Molecular cloning and characterization of a TAR-Binding nuclear factor from T cells. AIDS Res. Hum Retroviruses 11: 663-669, 1995.
8. Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG and Marasco WA: Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J 14: 1542-1551, 1995.
9. Chandra A, Demirhan I, Hofmann D and Chandra P: Design and development of inhibitors of transactivation of HIV- 1 LTR by the transactivator protein. International Conference on AIDS, Florence, 16.-21. June 1991 (Abstract W.A. 1063).
10. Chandra P, Gerber T and Chandra A: Novel features of Retroviruses associated with human diseases. FEBS Lett 265: 415-421, 1990.
11. Sadie MR, Bentner T, Josephs SE, Willis R and Wong-Staal F: Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. Proc Natl Acad Sci USA 85: 9224-9228, 1988.
12. Frankel AD, Bredt DS and Pabo CO:Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240: 70-73, 1988.
13. Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Haseltine WA and Rosen CA: Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 63: 1-8, 1989.
14. Chandra A, Demirhan I, Arya SK and Chandra P: D-Penicillamine inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein. FEBS Lett 256: 282-286, 1988.
15. Planas-Bohne F: Metabolism and Pharmacokinetics of Penicillamine in Rats. J Rheumatol 8: 35, 1981.
16. Kubota S, El-Farrash MA, Maki M, Harada S and Hatanaka H: 2,3-Dimercapto-1-Propanol inhibits HIV-1 tat activity, viral production and infectivity in vitro. AIDS Res Hum Retroviruses 6: 919-927, 1990.
17. Arya SK, Guo C, Josephs SF and Wong-Staal F: Trans-Activator gene of human T-Lymphotropic virus type III (HTLV-III). Science 229: 69-73, 1985.